Expression and activation of RAS and mitogen‐activated protein kinases in macrophages treatedin vitrowith cisplatin: Regulation by kinases, phosphatases and Ca2+/calmodulin
- 1 August 1999
- journal article
- research article
- Published by Wiley in Immunology & Cell Biology
- Vol. 77 (4), 356-363
- https://doi.org/10.1046/j.1440-1711.1999.00841.x
Abstract
Cisplatin (cis-dichlorodiammineplatinum II), a potent antitumour compound, stimulates immune responses by activating monocytes/macrophages and other cells of the immune system. However, the exact mechanism by which cisplatin activates these cells is poorly characterized and attempts are being made to understand this mechanism. Previous studies from this laboratory have shown that Lyn, a protein tyrosine kinase of the src family, and nuclear factor (NF)-κB are involved in cisplatin-induced macrophage activation. Recent studies suggest that the RAS and mitogen-activated protein (MAP) kinases function as a connecting link between activated lyn and NF-kB, which raises the possibility of their involvement in cisplatin-induced macrophage activation. Therefore, this study was undertaken to investigate the effect of cisplatin treatment on the expression/activation of RAS (a low molecular weight GTP-binding protein) and MAP kinases in murine peritoneal macrophages. The underlying mechanism of expression/activation of RAS and MAP kinases in cisplatin-treated macrophages was also investigated. Immunoblotting and immune-complex kinase assays revealed that cisplatin treatment of macrophages leads to increased expression/activation of RAS and MAP kinases, with optimal expression/activation at 15 min of treatment. Using a battery of specific inhibitor/modulators of different signalling molecules, this study shows that expression and activation of MAP kinases are two unrelated processes. It was also observed that kinase (protein tyrosine and protein kinase C) inhibitor and Ca2+/calmodulin antagonist inhibit expression/activation of RAS/MAP kinases in macrophages, whereas phosphatases (protein tyrosine and serine/threonine) inhibitor up-regulate these kinases.Keywords
Funding Information
- University Grants Commission
This publication has 42 references indexed in Scilit:
- Antigen presentation by cisplatin‐activated macrophages: Role of soluble factor(s) and second messengersImmunology & Cell Biology, 1998
- Mechanism of NF-κB translocation in macrophages treated in vitro with cisplatinImmunology Letters, 1998
- LFA‐1‐dependent tumoricidal activity of cisplatin‐treated macrophagesImmunology & Cell Biology, 1998
- Effect of lipoproteins on macrophage superoxide generationCell Biochemistry and Function, 1995
- Macrophage tumoricidal mechanismsResearch in Immunology, 1993
- Production of reactive nitrogen intermediates by bone marrow-derived macrophages on treatment with cisplatin in vitroClinical and Experimental Immunology, 1992
- ras mediates nerve growth factor receptor modulation of three signal-transducing protein kinases: MAP kinase, Raf-1, and RSKCell, 1992
- Activation of human NK cells and monocytes with cisplatin in vitroInternational Journal of Immunopharmacology, 1990
- Release of cytolytic factor(s) by murine macrophages in vitro on treatment with cis-PlatinInternational Journal of Immunopharmacology, 1986
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976